Skip to main content
PGNY $26.28 +1.51%
PGNY logo

PGNY · Progyny, Inc.

Track PGNY — free
$26.28 +0.39 (+1.51%) At close · Aug 14
Market Cap
$2.02B
Shares
76.73M
All earnings calls

Earnings call · FY2026 Q2

Progyny 2nd Quarter 2026 Earnings Conference Call

Progyny 2nd Quarter 2026 Earnings Conference Call

Concluded Aug 6, 2026
Aug 6, 2026 0 turns
Period
FY2026 Q2
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Forward guidance

10 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $350.51M +5.3% YoY
Diluted EPS $0.34 +78.9% YoY
Gross margin 25.5% +1.8 pp YoY
Net income $28.05M +63.9% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Aug 6, 2026.

Metric Guided
Revenue
Full Year 2026
$1.36B – $1.39B
Net income
Full Year 2026
$104.8M – $109.9M
Adjusted EBITDA
Full Year 2026
$233M – $240M
Net income per diluted share
Full Year 2026
$1.26 – $1.32
Adjusted earnings per diluted share
Full Year 2026
$2.04 – $2.10
Revenue
Third Quarter of 2026
$335M – $345M
Net income
Third Quarter of 2026
$24.5M – $26.7M
Adjusted EBITDA
Third Quarter of 2026
$56M – $59M
Net income per diluted share
Third Quarter of 2026
$0.30 – $0.33
Adjusted earnings per diluted share
Third Quarter of 2026
$0.50 – $0.52

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Fertility Benefit Services$230.21M +7.6% YoY
Pharmacy Benefit Services$120.30M +1.2% YoY

Capital returned

Buybacks · derived
$30.02M
Shares repurchased
1.19M
Full-screen source Call document